Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple scan replace the needle? new study tests Real-Time prostate cancer diagnosis

NCT ID NCT07709403

Not yet recruiting Diagnosis Sponsor: Peking University First Hospital Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study explores whether measuring radioactive counts from PSMA PET/CT-guided biopsy samples can instantly tell if a tissue core contains cancer. Researchers aim to find a cutoff value that reliably distinguishes cancerous from non-cancerous tissue, using standard pathology as the gold standard. If successful, this could reduce the need for multiple biopsy cores and eventually lead to a non-invasive, biopsy-free diagnosis of prostate cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could pave the way for a non-invasive, biopsy-free diagnosis of prostate cancer using imaging alone.
What could go wrong
This is a small, early-stage study with only 20 participants, so results may not apply broadly. The technique may not reliably replace traditional biopsies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.